Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;96:2353-2360

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Calnon, D. A.
Right arrow Articles by Ruiz, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Calnon, D. A.
Right arrow Articles by Ruiz, M.

(Circulation. 1997;96:2353-2360.)
© 1997 American Heart Association, Inc.


Articles

Effects of Dobutamine Stress on Myocardial Blood Flow, 99mTc Sestamibi Uptake, and Systolic Wall Thickening in the Presence of Coronary Artery Stenoses

Implications for Dobutamine Stress Testing

Dennis A. Calnon, MD; David K. Glover, ME; George A. Beller, MD; Gérald Vanzetto, MD; William H. Smith, MS; Denny D. Watson, PhD; ; Mirta Ruiz, MD

From the Experimental Cardiology Laboratory, Cardiovascular Division, Department of Medicine, University of Virginia Health Sciences Center, Charlottesville.

Background Although dobutamine stress is used with both 99mTc sestamibi (sestamibi) myocardial perfusion imaging and echocardiography for detecting coronary artery stenoses, the impact of stenosis severity on test end points (myocardial sestamibi uptake and systolic thickening, respectively) has not been clearly defined.

Methods and Results In 15 open-chest dogs, dobutamine (2.5 to 30 µg · kg-1 · min-1) was infused after placement of an LAD stenosis that reduced (n=8) or abolished (n=7) flow reserve. In dogs with reduced flow reserve, the stenotic-to-normal sestamibi activity ratio (0.86±0.03) significantly underestimated the {approx}2-to-1 dobutamine-induced flow disparity at the time of sestamibi injection (flow ratio, 0.53±0.04; P<.001). Stenotic-zone thickening increased at low but not at higher doses of dobutamine (2.9±0.4 versus 4.2±0.4 mm in normal zone at peak dobutamine; P=.055) but did not fall below baseline (2.7±0.3 mm). Similarly, in dogs with absent flow reserve, the sestamibi activity ratio (0.78±0.02) underestimated the {approx}2.5-to-1 dobutamine-induced flow disparity (flow ratio, 0.41±0.05; P<.001), and failure to increase systolic thickening was observed in the stenotic zone (2.7±0.4 versus 4.6±0.3 mm in the normal zone at peak stress, P<.01). In both groups of dogs, myocardial sestamibi uptake and image defect magnitudes were less than expected for the dobutamine-induced hyperemia, suggesting that dobutamine adversely affects myocardial sestamibi binding. Finally, a significant reduction in stenotic-zone thickening was seen during postdobutamine recovery, consistent with myocardial stunning.

Conclusions In the presence of stenoses that reduced or abolished regional flow reserve, (1) myocardial sestamibi uptake significantly underestimated the dobutamine-induced flow heterogeneity, (2) a "failure to increase systolic thickening" rather than a reduction in thickening was observed during dobutamine stress, and (3) myocardial stunning was observed during postdobutamine recovery.


Key Words: imaging • inotropic agents • radioisotopes • stunning, myocardial




This article has been cited by other articles:


Home page
Eur J EchocardiogrHome page
J. Thambyrajah, K. Vijayalakshmi, R.J. Graham, A.J. Turley, M.A. de Belder, and M.J. Stewart
Strain rate imaging pre- and post-percutaneous coronary intervention: a potential role in the objective detection of ischaemia in exercise stress echocardiography
Eur J Echocardiogr, February 12, 2008; (2008) jen035v1.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
M. L. Brown, T. M. Sundt III, and B. J. Gersh
Indications for Revascularization
Card. Surg. Adult, January 1, 2008; 3(2008): 551 - 572.
[Full Text]


Home page
CirculationHome page
B. Bijnens, P. Claus, F. Weidemann, J. Strotmann, and G. R. Sutherland
Investigating Cardiac Function Using Motion and Deformation Analysis in the Setting of Coronary Artery Disease
Circulation, November 20, 2007; 116(21): 2453 - 2464.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. K. Glover, M. Ruiz, K. Takehana, F. D. Petruzella, J. M. Rieger, T. L. Macdonald, D. D. Watson, J. Linden, and G. A. Beller
Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3164 - H3171.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. Yip, B. Khandheria, M. Belohlavek, C. Pislaru, J. Seward, K. Bailey, A. J. Tajik, P. Pellikka, and T. Abraham
Strain echocardiography tracks dobutamine-induced decrease in regional myocardial perfusion in nonocclusive coronary stenosis
J. Am. Coll. Cardiol., October 19, 2004; 44(8): 1664 - 1671.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
L. M. Riou, C. Ghezzi, G. Vanzetto, A. Broisat, J.-P. Mathieu, R. Bontron, R. Pasqualini, and D. Fagret
Verapamil Does Not Inhibit 99mTcN-NOET Uptake In Situ in Normal or Ischemic Canine Myocardium
J. Nucl. Med., June 1, 2003; 44(6): 981 - 987.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
T. M. Sundt III, B. J. Gersh, and H. C. Smith
Indications for Coronary Revascularization
Card. Surg. Adult, January 1, 2003; 2(2003): 541 - 559.
[Full Text]


Home page
JNMHome page
A. Elhendy, J. J. Bax, and D. Poldermans
Dobutamine Stress Myocardial Perfusion Imaging in Coronary Artery Disease
J. Nucl. Med., December 1, 2002; 43(12): 1634 - 1646.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
I. Ahmet, Y. Sawa, K. Iwata, and H. Matsuda
Gene transfection of hepatocyte growth factor attenuates cardiac remodeling in the canine heart: A novel gene therapy for cardiomyopathy
J. Thorac. Cardiovasc. Surg., November 1, 2002; 124(5): 957 - 963.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Ruiz, K. Takehana, F. D. Petruzella, D. D. Watson, G. A. Beller, and D. K. Glover
Arbutamine Stress Perfusion Imaging in Dogs with Critical Coronary Artery Stenoses: 99mTc-Sestamibi Versus 201Tl
J. Nucl. Med., May 1, 2002; 43(5): 664 - 670.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. A. Calnon, P. D. McGrath, A. L. Doss, F. E. Harrell Jr, D. D. Watson, and G. A. Beller
Prognostic value of dobutamine stress technetium-99m-sestamibi single-photon emission computed tomography myocardial perfusion imaging: stratification of a high-risk population
J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1511 - 1517.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P Lancellotti, T Benoit, P Rigo, and L A Pierard
Dobutamine stress echocardiography versus quantitative technetium-99m sestamibi SPECT for detecting residual stenosis and multivessel disease after myocardial infarction
Heart, November 1, 2001; 86(5): 510 - 515.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. K. Glover, M. Ruiz, K. Takehana, F. D. Petruzella, L. M. Riou, J. M. Rieger, T. L. Macdonald, D. D. Watson, J. Linden, and G. A. Beller
Pharmacological Stress Myocardial Perfusion Imaging With the Potent and Selective A2A Adenosine Receptor Agonists ATL193 and ATL146e Administered by Either Intravenous Infusion or Bolus Injection
Circulation, September 4, 2001; 104(10): 1181 - 1187.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K. Takehana, G. A. Beller, M. Ruiz, F. D. Petruzella, D. D. Watson, and D. K. Glover
Assessment of Residual Coronary Stenoses Using 99mTc-N-NOET Vasodilator Stress Imaging to Evaluate Coronary Flow Reserve Early After Coronary Reperfusion in a Canine Model of Subendocardial Infarction
J. Nucl. Med., September 1, 2001; 42(9): 1388 - 1394.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Lafitte, H. Matsugata, B. Peters, M. Togni, M. Strachan, O. L. Kwan, and A. N. DeMaria
Comparative Value of Dobutamine and Adenosine Stress in the Detection of Coronary Stenosis With Myocardial Contrast Echocardiography
Circulation, June 5, 2001; 103(22): 2724 - 2730.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
I. Matsunari, F. Haas, N. T.B. Nguyen, G. Reidel, I. Wolf, R. Senekowitsch-Schmidtke, G. Stöcklin, and M. Schwaiger
Comparison of Sestamibi, Tetrofosmin, and Q12 Retention in Porcine Myocardium
J. Nucl. Med., May 1, 2001; 42(5): 818 - 823.
[Abstract] [Full Text]


Home page
HeartHome page
P Lancellotti, A Albert, C Berthe, and L A Piérard
Full recovery of contraction late after acute myocardial infarction: determinants and early predictors
Heart, May 1, 2001; 85(5): 521 - 526.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
M. L. Geleijnse, A. Elhendy, P. M. Fioretti, and J. R. T. C. Roelandt
Dobutamine stress myocardial perfusion imaging
J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2017 - 2027.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Z.-X. He, E. Cwajg, W. Hwang, C. J. Hartley, E. Funk, L. H. Michael, and M. S. Verani
Myocardial Blood Flow and Myocardial Uptake of 201Tl and 99mTc-Sestamibi During Coronary Vasodilation Induced by CGS-21680, a Selective Adenosine A2A Receptor Agonist
Circulation, July 25, 2000; 102(4): 438 - 444.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Takehana, M. Ruiz, F. D. Petruzella, D. D. Watson, G. A. Beller, and D. K. Glover
Response to incremental doses of dobutamine early after reperfusion is predictive of the degree of myocardial salvage in dogs with experimental acute myocardial infarction
J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1960 - 1968.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
E Barnes, C S R Baker, D P Dutka, O Rimoldi, C A Rinaldi, P Nihoyannopoulos, P G Camici, and R J C Hall
Prolonged left ventricular dysfunction occurs in patients with coronary artery disease after both dobutamine and exercise induced myocardial ischaemia
Heart, March 1, 2000; 83(3): 283 - 289.
[Abstract] [Full Text]


Home page
HeartHome page
A Elhendy, R T van Domburg, J J Bax, D Poldermans, P R Nierop, M L Geleijnse, and J R T C Roelandt
The grade of worsening of regional function during dobutamine stress echocardiography predicts the extent of myocardial perfusion abnormalities
Heart, January 1, 2000; 83(1): 35 - 39.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M.-J. Hung, C.-H. Wang, and W.-J. Cherng
Can Dobutamine Stress Echocardiography Predict Cardiac Events in Nonrevascularized Diabetic Patients Following Acute Myocardial Infarction?
Chest, November 1, 1999; 116(5): 1224 - 1232.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. A. Calnon, M. Ruiz, G. Vanzetto, D. D. Watson, G. A. Beller, and D. K. Glover
Myocardial Uptake of 99mTc-N-NOET and 201Tl During Dobutamine Infusion : Comparison With Adenosine Stress
Circulation, October 12, 1999; 100(15): 1653 - 1659.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Bartunek, W. Wijns, G. R. Heyndrickx, and B. de Bruyne
Effects of Dobutamine on Coronary Stenosis Physiology and Morphology : Comparison With Intracoronary Adenosine
Circulation, July 20, 1999; 100(3): 243 - 249.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Gibbons, K. Chatterjee, J. Daley, J. S. Douglas, S. D. Fihn, J. M. Gardin, M. A. Grunwald, D. Levy, B. W. Lytle, R. A. O'Rourke, et al.
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina)
J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2092 - 2197.
[Full Text] [PDF]